HIF-2α-deficient tumours in that study were also characterised by enhanced antigen presentation, interferon signalling and CD8+ T cell infiltration and activation, suggesting an immune cell evading role of HIF-2α in ccRCC progression. This evidence concerns the gene EPAS1 and neoplasm.